Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Investor AB to Updates on Sale of Gambro to Baxter International Inc

Wednesday, 17 Jul 2013 08:00pm EDT 

Investor AB announced that the regulatory process to get the Gambro transaction cleared by the authorities is moving along, albeit slower than initially estimated. The transaction is now expected to close during the third quarter of 2013. On December 4, 2012, Investor (49%) and EQT (51%), signed an agreement to divest Gambro to the medical technology company Baxter International Inc. for an agreed total enterprise value of SEK 26.5 billion. According to the agreement, Gambro’s equity value will be based on the enterprise value after deduction of the net debt at the closing of the transaction.